BACcel system: Pilot trial data

A pilot trial analyzing 77 bronchoalveolar lavage (BAL) samples from 35 ICU patients at high-risk of developing pneumonia showed that Accelr8's BACcel rapid diagnostic system had 86% sensitivity and 97% specificity for detecting any of the 3 target bacterial organisms - methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa and Acinetobacter species. Furthermore, the results were reported within 4-6 hours after the lab received a specimen, which the company said is 40-66 hours faster than culturing. Data were presented at the American Thoracic Society meeting in Denver. ...